Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
2 hedge funds and large institutions have $412K invested in Forward Pharma A/S American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
71% less funds holding
Funds holding: 7 → 2 (-5)
85% less capital invested
Capital invested by funds: $2.69M → $412K (-$2.27M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.52M |
| 2 |
Morgan Stanley
New York
|
-$483K |
| 3 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$54K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
FWP Hedge Fund Activity: Q4 2022 in Review
2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2022, worth a combined $412K — down 85% from $2.69M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of FWP and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BVF Inc, exiting entirely with an estimated $1.52M sold.
- 2 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $412K of Forward Pharma A/S American Depositary Shares stock for Q4 2022, down 85% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q4 2022 and 5 closed out, a net change of -5 holders.
- The largest Forward Pharma A/S American Depositary Shares seller in Q4 2022 was BVF Inc, an estimated $1.52M sold.
Based on aggregated 13F filings for Q4 2022.